Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lynne Cheryl Bulger Insider Profile
4 Followers
Lynne Cheryl Bulger, Divisional Vice-President at Cipher Pharmaceuticals, holds 1.54K shares in Cipher Pharmaceuticals (Ticker: CPHRF).
Lynne Cheryl Bulger has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Lynne Cheryl Bulger's holdings
Insider Roles
Divisional Vice-President
Roles that Lynne Cheryl Bulger holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Lynne Cheryl Bulger
Lynne Cheryl Bulger's Trading History
List of latest transactions for each holding click on a transaction to see Lynne Cheryl Bulger's performance on stock
You May Also Like
Lynne Cheryl Bulger insider profile FAQ
What is the percentage of profitable transactions made by Lynne Cheryl Bulger?
The percentage of profitable transactions made by Lynne Cheryl Bulger is ―.
What is the average return per transaction made by Lynne Cheryl Bulger?
The average return per transaction made by Lynne Cheryl Bulger is ―.
What stocks does Lynne Cheryl Bulger hold?
Lynne Cheryl Bulger holds: CPHRF stocks.
What was Lynne Cheryl Bulger’s latest transaction?
Lynne Cheryl Bulger latest transaction was an Uninformative Sell of ―.
What was Lynne Cheryl Bulger's most profitable transaction?
Lynne Cheryl Bulger’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Lynne Cheryl Bulger's role in Cipher Pharmaceuticals?
Lynne Cheryl Bulger's role in Cipher Pharmaceuticals is Divisional Vice-President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.